This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola. At Q2 Solutions, we support infectious disease clinical trials with a variety of tools including:
Authors:
Ayaskant Pany, MD, Medical Laboratory Director and Scientific Advisor Tropical Diseases, Central Laboratories South Africa
Sorika van Niekerk, MSc, UP, SA, Senior Director/General Manager, Central Laboratories South Africa
Stephen Mortlock, DSc.
Wayne R. Hogrefe, Ph.D., D (ABMLI), Vice President, Vaccine unit
Related Services:
- Niche and novel assay development
- DNA & RNA extraction and next-generation sequencing
- Integrated local lab data management services
- Global laboratory network held to rigorous quality standards and biosafety protocols
Authors:
Ayaskant Pany, MD, Medical Laboratory Director and Scientific Advisor Tropical Diseases, Central Laboratories South Africa
Sorika van Niekerk, MSc, UP, SA, Senior Director/General Manager, Central Laboratories South Africa
Stephen Mortlock, DSc.
Wayne R. Hogrefe, Ph.D., D (ABMLI), Vice President, Vaccine unit
Related Services: